Jeff Johnson

Stock Analyst at Baird

(4.69)
# 170
Out of 4,893 analysts
143
Total ratings
60.2%
Success rate
30.58%
Average return

Stocks Rated by Jeff Johnson

The Cooper Companies
May 30, 2025
Maintains: Outperform
Price Target: $107$97
Current: $75.34
Upside: +28.75%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21$23
Current: $20.34
Upside: +13.08%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $130$115
Current: $93.77
Upside: +22.64%
DexCom
May 2, 2025
Maintains: Outperform
Price Target: $115$105
Current: $84.04
Upside: +24.94%
Tandem Diabetes Care
May 1, 2025
Maintains: Neutral
Price Target: $33$24
Current: $15.84
Upside: +51.52%
Alcon
Feb 27, 2025
Maintains: Outperform
Price Target: $104$108
Current: $87.83
Upside: +22.96%
Beta Bionics
Feb 20, 2025
Initiates: Neutral
Price Target: $20
Current: $13.55
Upside: +47.63%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378$405
Current: $391.15
Upside: +3.54%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325$276
Current: $201.95
Upside: +36.67%
Henry Schein
Aug 7, 2024
Maintains: Outperform
Price Target: $92$82
Current: $73.24
Upside: +11.97%
Upgrades: Outperform
Price Target: $180$238
Current: $294.64
Upside: -19.22%
Maintains: Outperform
Price Target: $67$70
Current: $34.81
Upside: +101.09%
Maintains: Outperform
Price Target: $53$61
Current: $14.81
Upside: +311.88%
Maintains: Outperform
Price Target: $78$67
Current: $16.30
Upside: +311.04%